Phagocytic activity and state of bactericidal systems in polymorphonuclear leukocytes from patients with Alzheimer's disease

被引：15
作者：
Davydova, TV [1 ]
Fomina, VG
Voskresenskaya, NI
Doronina, OA
机构：
[1] RAS, Inst Gen Pathol & Pathophysiol, Moscow, Russia
[2] Russian Acad Med Sci, State Res Ctr Mental Hlth, Moscow, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2003年 / 136卷 / 04期
关键词：
Alzheimer's disease; neutrophils; phagocytosis; myeloperoxidase; cationic proteins;
D O I：
10.1023/B:BEBM.0000010950.53560.e2
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Phagocytic activity of peripheral blood neutrophils underwent phase changes in patients with Alzheimer's disease. Neutrophils retained the ability to engulf microbes, but their digestive activity decreased at the early stage of Alzheimer's disease. At the. late stage we observed a decrease in the count of phagocytizing neutrophils, reduction of myeloperoxidase activity, and increase in the content of cationic proteins.
引用
收藏
页码：355 / 357
页数：3
相关论文
共 10 条
[1]  
ANDROSOVA LV, 1995, B EKSP BIOL MED, V119, P24
[2]   Cytokine levels and phagocytic activity in patients with Alzheimer's disease [J].
Beloosesky, Y ;
Salman, H ;
Bergman, M ;
Bessler, H ;
Djaldetti, M .
GERONTOLOGY, 2002, 48 (03) :128-132
[3]   Induction of immune complexes and autoantibodies to serotonin and dopamine in patients with Alzheimer's disease [J].
Davydova, TV ;
Mikovskaya, OI ;
Fomina, VG ;
Voskresenskaya, NI ;
Doronina, OT .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 134 (01) :23-25
[4]   AUTOANTIBODIES TO NEUROFIBRILLARY TANGLES AND BRAIN-TISSUE IN ALZHEIMERS-DISEASE - ESTABLISHMENT OF EPSTEIN-BARR VIRUS-TRANSFORMED ANTIBODY-PRODUCING CELL-LINES [J].
GASKIN, F ;
KINGSLEY, BS ;
FU, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) :245-250
[5]   Growing significance of myeloperoxidase in non-infectious diseases [J].
Hoy, A ;
Leininger-Muller, B ;
Kutter, D ;
Siest, G ;
Visvikis, S .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (01) :2-8
[6]   Autoantibodies to β-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type [J].
Myagkova, MA ;
Gavrilova, SI ;
Lermontova, NN ;
Kalyn, YB ;
Selezneva, ND ;
Zharikov, GA ;
Kolykhalov, IV ;
Abramenko, TV ;
Serkova, TP ;
Bachurin, SO .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 131 (02) :127-129
[7]  
Nägga AK, 1998, AGING-CLIN EXP RES, V10, P440
[8]   Translating cell biology into therapeutic advances in Alzheimer's disease [J].
Selkoe, DJ .
NATURE, 1999, 399 (6738) :A23-A31
[9]  
SHOTT K, 1996, PSYCHIAT RES, V59, P133
[10]  
Venglinskaia E A, 1976, Lab Delo, P270
1